High in situ rat intestinal permeability of artemisinin unaffected by multiple dosing and with no evidence of P-glycoprotein involvement

Drug Metabolism and Disposition

Volumn 27, Issue 2, 1999, Pages 227-232

  Svensson, Ulrika S H ^a   Sandström, Rikard ^a   Carlborg, Örjan ^a   Lennernäs, Hans ^a   Ashton, Michael ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISIN; GLYCOPROTEIN P; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG PENETRATION; DRUG TRANSPORT; INTESTINE ABSORPTION; JEJUNUM; MALE; MEMBRANE TRANSPORT; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIMALARIALS; ARTEMISININS; BIOLOGICAL AVAILABILITY; EMULSIONS; INTESTINAL ABSORPTION; JEJUNUM; MALE; P-GLYCOPROTEIN; PERFUSION; PERMEABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SESQUITERPENES; VERAPAMIL;

ANIMALIA;

EID: 0032912781     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Amidon GL, Kou J, Elliot RL and Lightfood EN (1980) Analysis of models for determining intestinal wall permeabilities. J Pharm Sci 69:1369-1373.
2. Amidon GL, Sinko P and Fleisher D (1988) Estimating human oral fraction dose absorbed: A correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm Res 5:651-654.
3. Artursson P, Palm K and Luthman K (1996) Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Delivery Rev 22:67-84.
4. Ashton M, Hai TN, Sy ND, Huong DX, Huong NV, Niêu NT and Cng LD (1998a) Artemisinin pharmacokinetics is time-dependent during repeated oral administration in healthy male adults. Drug Metab Dispos 26:25-27.
5. Ashton M, Sy ND, Gordi T, Hai TN, Thach DC, Huong NV, Farah MH, Johansson M and Cng LD (1996) Evidence for time-dependent artemisinin kinetics in adults with uncomplicated malaria. Pharm Pharmacol Lett 6:127-130.
6. Ashton M, Sy ND, Huong NV, Gordi T, Hai TN, Huong DX, Niêu NT and Cng LD (1998b) Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria. Clin Pharmacol Ther 63:482-493.
7. Augustijns P, D'Hulst A, van Daele J and Kinget R (1996) Transport of artemisinin and sodium artesunate in Caco-2 intestinal epithelial cells. J Pharm Sci 85:577-579.
8. Borst P, Schinkel AH, Smit JJM, Wagenaar E. van Deemter L, Smith AJ, Eijdems EWHM, Baas F and Zaman GJR (1993) Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals. Pharmacol Ther 60:289-299.
9. de Waziers I, Cugnenc PH, Yang CS, Leroux JP and Beaune PH (1990) Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther 253:387-394.
10. Edlund PO, Westerlund D, Carlqvist J, Bo-Liang W and Yunhua J (1984) Determination of artesunate and dihydroartemisinine in plasma by liquid Chromatography with post-column derivatization and UV-detection. Acta Pharm Suec 21:223-234.
11. Endicott JA and Ling V (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58:137-171.
12. Fagerholm U, Johansson M and Lennernäs H (1996) Comparison between permeability coefficients in rat and human jejunum. Pharm Res 13:1336-1342.
13. Foote SF, Kyle DE, Martin RK, Oduola AMJ, Forsyth K, Kemp DJ and Cowman AF (1990) Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature (London) 345:255-258.
14. Foote SJ, Thompson JK, Cowman AF and Kemp DJ (1989) Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 57:923-930.
15. Ford JM and Hait WN (1990) Pharmacology of drugs that after multidrug resistance in cancer. Pharmacol Rev 42:155-199.
16. Germann UA, Pastan I and Gottesman MM (1993) P-glycoproteins: Mediators of multidrug resistance. Sem Cell Biol 4:63-76.
17. Hassan Alin M, Ashton M, Kihamia CM, Mtey GJB and Björkman A (1996) Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. Trans Roy Soc Trop Med Hyg 90:61-65.
18. Hassan Alin M, Bjorkman A, Landberg-Lindgren A and Ashton M (1992) The effect of artemisinine, its derivatives and mefloquine against chloroquine-resistant strains of Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 86:365-367.
19. Kararli TT (1995) Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Disp 16:351-380.
20. Kim RB, Fromm MF, Wandel C, Leake B, Wood AJ, Roden DM and Wilkinson GR (1998) The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest 101:289-294.
21. Klayman DL (1985) Qinghaosu (artemisinin): An antimalarial drug from China. Science (Wash DC) 228:1049-1055.
22. Komiya I, Park JY, Kamani A, Ho NFH and Higuchi WI (1980) Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes. Int J Pharmaceutics 4:249-262.
23. Lennernäs H, Ahrenstedt O, Hällgren R, Knutson L, Ryde M and Paalzow LK (1992) Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man. Pharm Res 9:1243-1251.
24. Lown KS, Mayo RR, Leichtman AB, Hsiao HL, Turgeon DK, Schmiedlin-Ren P, Brown MB, Guo W, Rossi SJ, Benet LZ and Watkins PB (1997) Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther 62:248-260.
25. Saitoh H and Aungst BJ (1995) Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine. Pharm Res 12:1304-1310.
26. Sandström R, Karlsson A and Lennernäs H (1998) The absence of stereoselective P- glycoprotein-mediated transport of R/S-verapamil across the rat jejunum. J Pharm Phamacol 50:729-735.
27. Schultz R and Winne D (1987) Relationship between antipyrine absorption and blood flow rate in rat jejunum, ileum and colon. Naunyn-Schmiedeberg's Arch Pharmacol 335:97-102.
28. Sidhu JS, Ashton M, Huong NV, Karlsson MO, Sy ND, Jonsson EN and Cng LD (1998) Artemisinin population pharmacokinetics in children and adults with uncomplicated falciparum malaria. Br J Clin Pharmacol 45:347-354.
29. Silverman JA and Thorgeirsson SS (1995) Regulation and function of the multidrug resistance genes in liver. Prog Liver Dis 13:101-123.
30. Sparreboom A, van Asperen J, Mayer U, Schinkel AH, Smit JW, Meijer DKF, Borst P, Nooijen WJ, Beijnen JH and van Tellingen O (1997) Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci USA 94:2031-2035.
31. Svensson USH, Ashton M, Hai TN, Bertilsson L, Huong DX, Huong NV, Niẽu NT, Sy ND, Lykkesfeldt J and Cng LD (1998) Artemisinin induces omeprazole metabolism in human beings. Clin Pharmacol Ther 64:160-167.
32. Trigg PI (1989) Qinghaosu (artemisinin) as an antimalarial drug, in Qinghaosu (Artemisinin) as an Antimalarial Drug (Wagner H, Hikino H and Farnsworth NR eds) pp 19-55, Academic Press, London.
33. Tsuruo T, Iida H, Tskagoshi S and Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967-1972.
34. Wacher VJ, Wu CY and Benet LZ (1995) Overlapping substrate specificities and tissue distribution of cylochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy. Mol Carcinogen 13:129-134.
35. Watt G, Long GW, Grogl M and Martin SK (1990) Reversal of drug-resistant falciparum malaria by calcium antagonists: Potential for host cell toxicity. Trans R Soc Trop Med Hyg 84:187-190.
36. Wellems TE, Panton LJ, Gluzman IY, do Rosario VE, Gwadz RW, Walker-Jonah A and Krogstad DJ (1990) Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature (London) 345:253-255.